Jie Zeng

600 TianHe Rd
Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

GSH-responsive polyurethane/PBAT blend films: degradation kinetics, ecotoxicity screening, and governance-carbon coupling via three-tier mapping.

GSH-responsive polyurethane/PBAT blend films: degradation kinetics, ecotoxicity screening, and governance-carbon coupling via three-tier mapping.

Journal: RSC advances

Published: May 10, 2026

Association between gut microbiota characteristics and therapeutic efficacy of multimodal combination therapy in hepatocellular carcinoma with portal vein tumor thrombus: a secondary analysis of a prospective phase II trial.

Association between gut microbiota characteristics and therapeutic efficacy of multimodal combination therapy in hepatocellular carcinoma with portal vein tumor thrombus: a secondary analysis of a prospective phase II trial.

Journal: Frontiers in immunology

Published: April 25, 2026

Nitrate contamination in a karst aquifer affected by acid mine drainage during a storm event: Insights from stable isotopes and hydrochemical tracers.

Nitrate contamination in a karst aquifer affected by acid mine drainage during a storm event: Insights from stable isotopes and hydrochemical tracers.

Journal: Journal of hazardous materials

Published: March 21, 2026

Amygdalin alleviates MAFLD via inhibiting cytoplasmic calcium ion overload-induced liver sinusoidal endothelial cell defenestration.

Amygdalin alleviates MAFLD via inhibiting cytoplasmic calcium ion overload-induced liver sinusoidal endothelial cell defenestration.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 21, 2025

Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical study.

Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical study.

Journal: Journal of gastrointestinal oncology

Published: September 05, 2025

Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial.

Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial.

Journal: Frontiers in immunology

Published: August 17, 2025

Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion.

Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion.

Journal: Journal of hepatocellular carcinoma

Published: August 14, 2025

A CART-based prognostic model for risk stratification of postoperative early recurrence in hepatocellular carcinoma with microvascular invasion.

A CART-based prognostic model for risk stratification of postoperative early recurrence in hepatocellular carcinoma with microvascular invasion.

Journal: Frontiers in oncology

Published: July 04, 2025

Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study.

Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study.

Journal: Hepatobiliary surgery and nutrition

Published: July 04, 2024

Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase II Study.

Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase II Study.

Journal: The oncologist

Published: March 01, 2023

Tracking contaminants in groundwater flowing across a river bottom within a complex karst system: Clues from hydrochemistry, stable isotopes, and tracer tests.

Tracking contaminants in groundwater flowing across a river bottom within a complex karst system: Clues from hydrochemistry, stable isotopes, and tracer tests.

Journal: Journal of environmental management

Published: February 26, 2023

A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma.

A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma.

Journal: Journal of gastrointestinal oncology

Published: January 03, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026